(Press-News.org) In a world first, Canadian scientists at the CRCHUM, the hospital research centre affiliated with Université de Montréal, have identified microRNA able to protect small blood vessels and support kidney function after severe injury.
For the four million people diagnosed with chronic renal failure in Canada—and millions more abroad—this scientific advancement could have a major impact on early diagnosis and prevention of the disease.
Previously, there was no known reliable biomarker for evaluating the health of these capillaries and for developing targeted approaches to preserve kidney function.
In a study published last Thursday in JCI Insight, the CRCHUM research team shows that miR-423-5p microRNA is a promising marker in the blood for predicting the microvascular health of the kidneys.
UdeM medical professors Marie-Josée Hébert and Héloïse Cardinal, holders of the Shire Chair in Nephrology, Renal Transplantation and Regeneration, co-authored the study with Hébert’s research associate Francis Migneault.
Their specialty is studying the loss of peritubular capillaries, a conclusive indicator of chronic renal failure.
Located in the kidneys, millions of these small blood vessels filter waste products out of the blood and transport the oxygen and nutrients necessary for the organ’s functions.
Kidney injuries, caused by the temporary interruption and restoration of blood flow, can lead to a decrease in the number of small blood vessels, seriously disrupting kidney function.
“In people who have received a transplant, if kidney function is severely altered, the kidney’s survival is threatened,” said Hébert, a nephrology-transplant physician and UdeM’s outgoing vice-rector for research, discovery, creation and innovation.
“Using this biomarker, a test could be developed to evaluate the status of the small blood vessels much earlier,” she said. “Doctors in hospitals could then better evaluate the microvascular health of higher-risk patients.
“These could include elderly patients or those undergoing surgeries during which blood flow is temporarily stopped, as is the case for organ transplants or cardiovascular interventions.”
Of mice and… 51 transplant recipients
“We first observed fluctuating levels of miR-423-5p microRNA in the blood of mice with acute kidney injuries,” said Migneault, the study’s first author. “These results were then confirmed in 51 transplant recipients who participated in the CHUM kidney transplant biobank.”
Thanks to this biomarker, clinical teams could confirm whether their interventions improve or diminish the health of small blood vessels.
“But what’s really incredible is that by injecting this microRNA into mice with kidney injuries, we were able to preserve the small blood vessels and limit the damage done to the kidneys,” said Migneault.
While direct injection into the kidney is a clinically feasible method during a transplant, to protect the remaining small blood vessels, the CRCHUM scientists are now focused on alternative techniques to transport the microRNA, or likely a microRNA cocktail, to the kidney.
Potentially useful for other patients
In terms of prevention, a test based on this miR-423-5p microRNA could be useful for patients with cardiac failure, pulmonary failure or certain neurodegenerative diseases.
“For these medical conditions, the loss of small blood vessels plays a key role, because of the association with normal or accelerated aging,” said Hébert. “Our discovery could, therefore, have a significant impact on the health of all Canadians.”
For those with pulmonary failure, several research projects are in progress under Emmanuelle Brochiero, a researcher and head of the Immunopathology research theme at the CRCHUM.
It may also be possible, using the CHUM’s biological material biobank, to determine if existing medications, administered after a kidney transplant to treat another issue, impact small blood vessel health, added Hébert.
Author: Bruno Geoffroy
####
About this study
“Endothelial extracellular vesicle miR-423-5p regulates microvascular homeostasis and renal function after ischemia-reperfusion injury,” by Francis Migneault under the supervision of Dr. Marie-Josée Hébert et al., was published May 22, 2025, in JCI Insight. The results of this study are part of the provisional patent application US63/777,825, titled “Methods and agents for assessing and promoting microvascularization,” was filed on March 26, 2025.
This research was funded by the Canadian Institutes of Health Research, the Shire Chair in Nephrology, Renal Transplantation and Regeneration at Université de Montréal, the Fondation J.-Louis Lévesque, the Canadian Donation and Transplantation Research Program, the Fonds de recherche du Québec—Santé, and the Natural Sciences and Engineering Research Council of Canada. It was supported by the molecular pathology and animal core facility teams.
Dr. Hébert, Dr. Cardinal, Francis Migneault and the members of their team would like to thank the CHUM patients for their participation in the CHUM kidney transplant biobank, as well as the clinical and research staff who ensure the continued existence of the biobank.
About the CHUM Research Centre (CRCHUM)
Université de Montréal's affiliated hospital research centre, the CRCHUM, is one of North America’s leading hospital research centres. It strives to improve the health of adults through a continuum of research spanning disciplines such as basic science, clinical research and population health. About 2,130 people work at CRCHUM. These include more than 550 researchers and nearly 530 graduate students and postdoctoral fellows. crchum.com
About Université de Montréal
Deeply rooted in Montréal and dedicated to its international mission, Université de Montréal is one of the top universities in the French-speaking world. Founded in 1878, Université de Montréal today has 13 faculties and schools, and together with its two affiliated schools, HEC Montréal and Polytechnique Montréal, constitutes the largest centre of higher education and research in Québec and one of the major centres in North America. It brings together 2,300 professors and researchers and has close to 67,000 students. umontreal.ca
END
DARIEN, IL – A new study to be presented at the SLEEP 2025 annual meeting quantifies the amount of sleep loss experienced by first-time mothers in the weeks after giving birth and is the first to identify the unique type of sleep disruption that persists throughout the first months of motherhood.
Results show that the average daily sleep duration of new mothers was 4.4 hours during the first week after giving birth compared with a pre-pregnancy sleep duration of 7.8 hours. Their longest stretch of uninterrupted sleep also fell from 5.6 hours at pre-pregnancy to 2.2 hours in the first week after delivery. Nearly one-third of participants (31.7%) went more than 24 hours without sleep ...
Philadelphia, May 27, 2025 – Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link between central fat and psoriasis remained consistent regardless of genetic predisposition, indicating that abdominal fat is an independent risk factor. The study in the Journal of Investigative Dermatology, published by Elsevier, provides insights that could help improve early risk prediction and guide personalized prevention strategies.
Psoriasis is a chronic inflammatory skin condition that can have a significant impact on quality of life. Many individuals with psoriasis also ...
A UC Riverside-led study has found that a smartphone app that tracks household water use and alerts users to leaks or excessive consumption offers a promising tool for helping California water agencies meet state-mandated conservation goals.
Led by Mehdi Nemati, an assistant professor of public policy at UCR, the study found that use of the app—called Dropcountr—reduced average household water use by 6%, with even greater savings among the highest water users.
Dropcountr works by interpreting water-use data from smart water meters, which many utilities originally ...
Scientists have found that global warming in the Middle East and North Africa is making breast, ovarian, uterine, and cervical cancer more common and more deadly. The rise in rates is small but statistically significant, suggesting a notable increase in cancer risk and fatalities over time.
“As temperatures rise, cancer mortality among women also rises — particularly for ovarian and breast cancers,” said Dr Wafa Abuelkheir Mataria of the American University in Cairo, first author of the article in Frontiers ...
How long have you been doing your current job? Have you ever thought about trying a new profession? How difficult does change seem to you? The current rapid transformation of the labor market is putting many workers to the test: they struggle to keep up and move into new roles, while at the same time companies are having difficulty finding qualified personnel. A new study has analyzed the French labor market using methods from statistical physics, and found that over 90% of jobs today function as bottlenecks: they are easily accessible, but once entered, they become traps from which ...
Milan, Italy: Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide prescribing in routine care could lead to better outcomes for patients and save money for health systems.
Generating pharmacogenomic data in the laboratory is relatively straightforward, but a major challenge is making that information available to frontline healthcare professionals in a clinically relevant format and timeframe. This has meant that, to date, only a limited numbers of patients have been able to benefit from such individually optimised treatments.
Dr John McDermott, ...
Embargoed for release until 5:00 p.m. ET on Monday 26 May 2025
Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing ...
How does a bird learn its birdsong? Tomoko Fujii and Masashi Tanaka, from Waseda University, explored what drives a zebra finch to approach and imitate other zebra finches to learn its birdsong in a new JNeurosci paper.
The researchers explored song learning in young male zebra finches as they interacted with “tutor” adults that already knew their birdsongs. Young zebra finches preferably approached tutors that sang longer but less frequently. Fujii and Tanaka next probed the role of a brain region traditionally linked to emotions in mammals (the amygdala) in this song-learning process. To examine the ...
Background and objectives
Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation sequencing (NGS), the disease is challenging to treat due to the limited number of detectable mutations for targeted drug therapy. This study aimed to evaluate the mutation profiles of LSCC detected by NGS to assess the relationships between different driver mutations and clinicopathological parameters.
Methods
NGS ...
FRANKFURT. Otodus megalodon was the largest predatory fish in Earth’s history: Measuring up to 24 meters, it was longer than a truck with a trailer and weighed almost twice as much. Embedded in its jaws were triangular teeth the size of a hand, and its bite had the force of an industrial hydraulic press. It swam through the world’s oceans between 20 and 3 million years ago, frequently on the hunt for prey to satisfy a calorie demand as vast as its size: According to estimates, it required around 100,000 kilocalories per day. Science widely assumed that megalodon’s main calorie intake was in the form of ...
